Showing results (301-310 of 397) with videos related to
Sort By:
Pageof 40
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1989
Intraperitoneal cisplatin and etoposide in the treatment of refractory/recurrent ovarian carcinomaB Reichman, M Markman, T Hakes, et al.Gynecologic Oncology|May 30, 2009
Single-agent trabectedin as second-line therapy of persistent or recurrent endometrial cancer: results of a multicenter phase II studyD S McMeekin, A Lisyanskaya, M Crispens, et al.Journal of Cancer Research and Clinical Oncology|January 11, 1992
Salvage intraperitoneal therapy of small-volume residual ovarian cancer: impact of pretreatment finding of peritoneal carcinomatosis on the surgical complete response rateM Markman, B Reichman, T Hakes, et al.Cancer Research|December 1, 1994
Simultaneous dose escalation and schedule intensification of carboplatin-based chemotherapy using peripheral blood progenitor cells and filgrastim: a phase I trialD Fennelly, C Wasserheit, J Schneider, et al.Gynecologic Oncology|May 1, 1993
The use of recombinant human erythropoietin to prevent carboplatin-induced anemiaM Markman, B Reichman, T Hakes, et al.Journal of the National Cancer Institute. Monographs|January 1, 1993
Intraperitoneal administration of Taxol in the management of ovarian cancerM Markman, E Rowinsky, T Hakes, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2001
Carboplatin skin testing: a skin-testing protocol for predicting hypersensitivity to carboplatin chemotherapyK M Zanotti, L A Rybicki, A W Kennedy, et al.Gynecologic Oncology|July 1, 1993
Mitomycin-C plus a 3-day continuous intravenous infusion of 5-fluorouracil: an inactive salvage regimen for platinum-resistant ovarian carcinomaB Reichman, M Markman, T Hakes, et al.Gynecologic Oncology|February 1, 1993
Evidence for persistence of mitoxantrone within the peritoneal cavity following intraperitoneal deliveryM Markman, D Alberts, S Rubin, et al.Gynecologic Oncology|May 1, 1993
Impact of age on survival of patients with ovarian cancerM Markman, J L Lewis, P Saigo, et al.Pageof 40